Article Details
Retrieved on: 2024-11-05 17:30:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
After promising results from preclinical studies, HuidaGene is initiating a phase 1 dose finding trial for the therapy. “This open IND for HG202 by ...
Article found on: www.healio.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here